Lista de obras - Sahar Saeed - Dominio Público Uruguay

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015)

article

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection

artículo científico publicado en 2017

Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection.

artículo científico publicado en 2011

CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.

artículo científico publicado en 2014

Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study

article

Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.

artículo científico publicado en 2014

Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.

artículo científico publicado en 2008

Cystic fibrosis mouse models

artículo científico publicado en 2006

Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.

artículo científico publicado en 2017

Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls

article

Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus

artículo científico publicado en 2012

Fenretinide corrects newly found ceramide deficiency in cystic fibrosis

artículo científico publicado en 2008

Fenretinide prevents the development of osteoporosis in Cftr-KO mice.

artículo científico publicado en 2007

HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression

artículo científico publicado en 2010

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.

artículo científico publicado en 2018

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan

artículo científico publicado en 2016

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

artículo científico publicado en 2016

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.

artículo científico publicado en 2010

Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients

artículo científico publicado en 2012

Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

artículo científico publicado en 2018

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients

article

Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.

artículo científico publicado en 2010

Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.

artículo científico publicado en 2018

Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals

article

Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study

artículo científico publicado en 2016

Segmented generalized mixed effect models to evaluate health outcomes.

artículo científico publicado en 2018

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.

artículo científico publicado en 2016

Lista de obras de Sahar Saeed

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015)

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection

Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection.

CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.

Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study

Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.

Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.

Cystic fibrosis mouse models

Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.

Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls

Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus

Fenretinide corrects newly found ceramide deficiency in cystic fibrosis

Fenretinide prevents the development of osteoporosis in Cftr-KO mice.

HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.

Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients

Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients

Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.

Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.

Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals

Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study

Segmented generalized mixed effect models to evaluate health outcomes.

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.